Autoantibodies in patients with obsessive-compulsive disorder: a systematic review
- PMID: 37400462
- PMCID: PMC10318087
- DOI: 10.1038/s41398-023-02545-9
Autoantibodies in patients with obsessive-compulsive disorder: a systematic review
Abstract
Obsessive-compulsive disorder (OCD) is a frequent and debilitating mental illness. Although efficacious treatment options are available, treatment resistance rates are high. Emerging evidence suggests that biological components, especially autoimmune processes, may be associated with some cases of OCD and treatment resistance. Therefore, this systematic literature review summarizing all case reports/case series as well as uncontrolled and controlled cross-sectional studies investigating autoantibodies in patients with OCD and obsessive-compulsive symptoms (OCS) was performed. The following search strategy was used to search PubMed: "(OCD OR obsessive-compulsive OR obsessive OR compulsive) AND (antib* OR autoantib* OR auto-antib* OR immunoglob* OR IgG OR IgM OR IgA)". Nine case reports with autoantibody-associated OCD/OCS were identified: five patients with anti-neuronal autoantibodies (against N-methyl-D-aspartate-receptor [NMDA-R], collapsin response mediator protein [CV2], paraneoplastic antigen Ma2 [Ma2], voltage gated potassium channel complex [VGKC], and "anti-brain" structures) and four with autoantibodies associated with systemic autoimmune diseases (two with Sjögren syndrome, one with neuropsychiatric lupus, and one with anti-phospholipid autoantibodies). Six patients (67%) benefited from immunotherapy. In addition, eleven cross-sectional studies (six with healthy controls, three with neurological/psychiatric patient controls, and two uncontrolled) were identified with inconsistent results, but in six studies an association between autoantibodies and OCD was suggested. In summary, the available case reports suggest an association between OCD and autoantibodies in rare cases, which has been supported by initial cross-sectional studies. However, scientific data is still very limited. Thus, further studies on autoantibodies investigated in patients with OCD compared with healthy controls are needed.
© 2023. The Author(s).
Conflict of interest statement
DD: None. KR: None. BF: None. BP: None. KP: None. AS: None. KN: None. UV: None. LTvE: Advisory boards, lectures, or travel grants within the last three years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen, and Cyberonics. KD: Steering Committee Neurosciences, Janssen. Speaker fees from Janssen. MAS: None. DE: None.
Figures

Similar articles
-
Immunological causes of obsessive-compulsive disorder: is it time for the concept of an "autoimmune OCD" subtype?Transl Psychiatry. 2022 Jan 10;12(1):5. doi: 10.1038/s41398-021-01700-4. Transl Psychiatry. 2022. PMID: 35013105 Free PMC article. Review.
-
Could the Thyroid Gland Dominate the Brain in Obsessive-Compulsive Disorder?Neuroendocrinology. 2022;112(12):1143-1154. doi: 10.1159/000524627. Epub 2022 Apr 20. Neuroendocrinology. 2022. PMID: 35443249 Review.
-
Cerebrospinal fluid findings in adult patients with obsessive-compulsive disorder: A retrospective analysis of 54 samples.World J Biol Psychiatry. 2023 Apr;24(4):292-302. doi: 10.1080/15622975.2022.2104457. Epub 2022 Aug 26. World J Biol Psychiatry. 2023. PMID: 35904379
-
Religious attitudes in adolescents with Obsessive Compulsive Symptoms OCS and disorder OCD.Glob J Health Sci. 2012 Oct 28;4(6):216-21. doi: 10.5539/gjhs.v4n6p216. Glob J Health Sci. 2012. PMID: 23121759 Free PMC article.
-
Obsessive-compulsive symptoms are associated with psychiatric comorbidities, behavioral and clinical problems: a population-based study of Brazilian school children.Eur Child Adolesc Psychiatry. 2016 Feb;25(2):175-82. doi: 10.1007/s00787-015-0723-3. Epub 2015 May 27. Eur Child Adolesc Psychiatry. 2016. PMID: 26015374
Cited by
-
Exploring the role of interleukin-1β and interleukin-6 in the pathophysiology of obsessive-compulsive disorder.PLoS One. 2024 Jun 26;19(6):e0306125. doi: 10.1371/journal.pone.0306125. eCollection 2024. PLoS One. 2024. PMID: 38924009 Free PMC article.
-
The development of opioid vaccines as a novel strategy for the treatment of opioid use disorder and overdose prevention.Int J Neuropsychopharmacol. 2025 Feb 4;28(2):pyaf005. doi: 10.1093/ijnp/pyaf005. Int J Neuropsychopharmacol. 2025. PMID: 39831679 Free PMC article. Review.
References
-
- Glazier K, Calixte RM, Rothschild R, Pinto A. High rates of OCD symptom misidentification by mental health professionals. Ann Clin Psychiatry. 2013;25:201–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous